Implications of Mid-Study Clinical Trial Protocol Changes

Medidata & Tufts Center for the Study of Drug Development announced results of a study on the impact of protocol amendmends made while a clinical trial is underway. The study discussed their avoidability, costs and time delays.

Read the full release here

Read more in Kenneth Getz’s column this month here